Why It's Never Too Early For Small Biotechs To Harness Clinical Data With An Integrated Infrastructure

By Tyler Hoey and Dana MacDonald, PMP

On March 24, 2022, Halloran collaborated with CSL Behring to host a Town Hall on "Moving from Excel to Complete Integration for Better Clinical Trial Decisions." The event featured Tony Ciliberto, Senior Director of Global Clinical Operations, Charles Johnson, Director of eClinical Solutions, both from CSL Behring, and Meaghan Powers, Director of Clinical Practice Operations, and Karen Travers, Consultant, from Halloran.

The Town Hall commenced with CSL Behring sharing their data journey, highlighting their challenges as a heavily outsourced company utilizing diverse systems and data sources across their portfolio. They outlined the issues encountered and detailed their successful development of a streamlined, integrated data approach with the right team. Recognizing the value of their insights for the life science community, partnering with CSL Behring for the Town Hall provided an excellent opportunity to showcase their case study.

This article aims to further elaborate on the Town Hall insights, focusing on two key takeaways from the discussion. Firstly, it emphasizes the importance of initiating the integration of clinical data sources early on, irrespective of company size. Secondly, it delves into strategies for obtaining organizational buy-in for the integration process, providing valuable guidance for stakeholders navigating this transformative journey